Healthtech Startups

Telesair develops medical devices focused on patient care, with work spanning strategy, design, engineering, and quality assurance.

1 investor

Telesis Bio, Inc. is a company whose corporate governance page describes its Board of Directors and governance practices. The page does not describe the company's products or business activities.

1 investor

Telesofia provides a platform that generates personalized educational videos to explain medical conditions, treatment plans, and wellness guidance to patients. It serves healthcare organizations aiming to improve patient engagement, understanding, and treatment adherence.

1 investor

Telespro Finland specializes in high-quality and innovative medical and emergency response products, with particular expertise in perioperative thermal management for surgical patients and protective clothing for emergency personnel.

1 investor

Otto (TeleVet) builds technology for veterinary clinics and animal hospitals to help them connect with pet owners and manage their practice. The platform focuses on tools that support veterinarians' workflows and quality of life.

1 investor

Teligant is an all-in-one telehealth platform that handles patient intake, provider network, pharmacy fulfillment, patient management, and multi-state compliance so operators can launch a prescription wellness brand without developers. It serves wellness and longevity clinics, med spas, weight loss and men's health clinics, personal trainers, and telehealth entrepreneurs.

1 investor

Tell develops natural speech metrics to provide objective assessments of neurocognition, offering markers of brain disorders and neurocognitive decline in clinical settings and predictors of language development and school performance in educational settings. It serves clinicians, educators, companies, institutions, and academic researchers through study design, data analytics, neurocognitive screening, and research solutions.

1 investor

Tellescope provides a unified platform for digital health companies to manage patient communications, appointments, and care team operations. The platform includes patient portals, workflow automation, telehealth capabilities, and integrations with existing EHR systems.

1 investor

Tellgen is a Chinese in vitro diagnostics company that develops, manufactures, and sells diagnostic products and reagents for clinical laboratories. The company specializes in tumor markers, HPV detection, genetic mutation testing, autoimmune disease markers, and biochemical reagents using technologies including flow cytometry, chemiluminescence, and mass spectrometry.

1 investor

TELLUS Sensors manufactures professional-grade air quality monitors that track multiple pollutants and environmental parameters for residential, commercial, industrial, and research applications. The company provides both hardware monitors and a cloud-based data visualization platform for real-time air quality insights.

1 investor

Telomere Therapeutics is a gene therapy company developing treatments that repair telomeres to address organ fibrosis and telomere-dysfunction syndromes. Its lead program is an AAV-based therapy for idiopathic pulmonary fibrosis (IPF).

1 investor

Telosair provides indoor air quality monitoring and optimization solutions, partnering with HVAC and building automation experts, resellers, and installers. It serves research facilities and enterprises.

1 investor

Teleradiology Solutions provides remote medical imaging interpretation services for CT scans, MRIs, X-rays, ultrasounds, nuclear medicine, and echocardiograms to hospitals worldwide. The company serves over 144 hospitals across 9 countries including the United States, Singapore, and India.

1 investor

Tempo Therapeutics is a biotechnology company developing therapeutics, with a focus that includes dermatology. Its team works on a pipeline built around its underlying technology platform.

1 investor

Temprian Oncology develops nanoparticle-based "Supercarriers" that deliver a prodrug toxic to melanoma cells, releasing the active ingredient inside metastatic melanoma tumor cells in low-pH pigment-making organelles. The therapy targets late-stage, metastasized melanoma and is designed to work alongside or replace existing TKI and immune checkpoint inhibitor treatments.

1 investor

Temprian Therapeutics is a biopharmaceutical company developing an HSP70i-based immunotherapy for vitiligo. It focuses on advancing a treatment for pigmentation disorders through clinical development.

1 investor

TEM Saúde uses technology to connect people to a network of health professionals and services, offering discounts on medical, dental, and pharmacy services plus 24h telemedicine and health check-ups. It sells these health services to businesses—such as banks, retailers, insurers, and employers—as customer loyalty tools or employee benefits in Brazil.

1 investor

IBSRELA is a prescription medication containing tenapanor designed to treat irritable bowel syndrome with constipation (IBS-C) in adults by reducing constipation and abdominal pain. The drug works by increasing intestinal water retention, supporting gut lining integrity, and reducing pain-sensing nerve sensitivity.

1 investor

Tenax Therapeutics is a clinical-stage pharmaceutical company developing TNX-103, an oral formulation of the drug levosimendan, to treat pulmonary hypertension resulting from heart failure with preserved ejection fraction (PH-HFpEF). The company focuses on this cardiovascular and pulmonary disease, which currently has no approved treatments.

1 investor

Tend is a primary care network in New Zealand offering in-person medical centres and 24/7 online GP consultations, with an app that handles booking, consultations, results and family health records. It serves patients across Aotearoa New Zealand, with enrolment available in Auckland, Bay of Plenty and Canterbury.

1 investor

Tend develops therapeutic solutions and diagnostic tools focused on the gut microbiome to treat chronic intestinal and digestive health conditions. The company serves researchers, clinicians, and patients seeking evidence-based alternatives to traditional disease management approaches.

1 investor

TendoNova develops microinvasive medical technology, including its Ocelot Nano device, to treat chronic tendon pain in patients. The company targets clinical use for patients with tendon injuries, including athletes.

1 investor

Tenmile is an Australian health technology venture capital firm that funds and supports early-stage biotech and medtech innovations with the goal of bringing Australian research breakthroughs to global markets. Beyond capital, the firm provides portfolio companies with talent recruitment support, international partnerships, and regulatory guidance.

1 investor

Tenomix develops intelligent automation technology for cancer diagnostics and healthcare labs to improve diagnostic speed and accuracy while addressing staffing shortages and rising patient caseloads. The company works with clinical partners across North America, embedding automation into existing lab workflows.

1 investor